The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, December 11, 2012
Aptalis Pharma U.S., Inc., a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis (CF), announced that ...
read more
Friday, November 30, 2012
A recent experimental study demonstrates the ability of the Morphologi G3-ID particle characterization system from Malvern Instruments to efficiently ...
read more
Thursday, November 01, 2012
Local and state government officials joined representatives from Eli Lilly and Company today to announce a $140 million expansion to the company's ...
read more
Thursday, October 11, 2012
West Pharmaceutical Services, Inc., a global leader in innovative system and component solutions for injectable drug administration, today announced ...
read more
Wednesday, September 26, 2012
Today Capsugel unveiled its newly expanded executive leadership team. Since becoming a standalone company from Pfizer in August 2011, President and ...
read more
Thursday, September 13, 2012
Metro Charlotte-based Ei, A Pharmaceutical SolutionWorks has signed agreements with European-based professors and technologists for the exclusive ...
read more
Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD Tablets (orally disintegrating tablets (ODT)), which ...
read more
Celanese EVA Performance Polymers invites the pharmaceutical industry to participate in dialog around ethylene vinyl acetate (EVA) polymer technology ...
read more
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has entered into a definitive ...
read more
Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing differentiated oral products utilizing its ...
read more
AstraZeneca (NYSE: AZN) and The Medicines Company (NASDAQ: MDCO) announced today a global collaboration for acute ischemic heart disease compounds. ...
read more
Apricus Biosciences, Inc.
("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com), announced today that the Company received an ...
read more
Wednesday, April 25, 2012
Repligen Corporation (Nasdaq:RGEN) today announced positive results from a Phase 1 study to evaluate the pharmacokinetic (PK) and safety profile of ...
read more
Wednesday, April 25, 2012
Donald E. Morel, Jr. Ph.D., chairman and CEO of West Pharmaceutical Services, Inc. (NYSE: WST), and Scottsdale Mayor W.J. “Jim” Lane will host ...
read more
DUSA Pharmaceuticals, Inc.(R) (Nasdaq:DUSA), a dermatology company that is developing and marketing its Levulan(R) Photodynamic Therapy (PDT) platform...
read more